All Stories

  1. Stem cell‐derived extracellular vesicles reduce the expression of molecules involved in cardiac hypertrophy—In a model of human-induced pluripotent stem cell-derived cardiomyocytes
  2. Microvesicles and Microvesicle-Associated microRNAs Reflect Glioblastoma Regression: Microvesicle-Associated miR-625-5p Has Biomarker Potential
  3. VLA4-Enhanced Allogeneic Endothelial Progenitor Cell-Based Therapy Preserves the Aortic Valve Function in a Mouse Model of Dyslipidemia and Diabetes
  4. Therapeutic Potential of Stem Cell-Derived Extracellular Vesicles on Atherosclerosis-Induced Vascular Dysfunction and Its Key Molecular Players
  5. The Multifaceted Role of Extracellular Vesicles in Glioblastoma: microRNA Nanocarriers for Disease Progression and Gene Therapy
  6. Extracellular vesicles—incorporated microRNA signature as biomarker and diagnosis of prediabetes state and its complications
  7. Extracellular Vesicles: Versatile Nanomediators, Potential Biomarkers and Therapeutic Agents in Atherosclerosis and COVID-19-Related Thrombosis
  8. Extracellular Vesicles from Adipose Tissue Stem Cells in Diabetes and Associated Cardiovascular Disease; Pathobiological Impact and Therapeutic Potential
  9. Part One: Extracellular Vesicles as Valuable Players in Diabetic Cardiovascular Diseases
  10. Part Two: Extracellular Vesicles as a Risk Factor in Neurodegenerative Diseases
  11. Intravenous Administration of Allogenic Cell-Derived Microvesicles of Healthy Origins Defends Against Atherosclerotic Cardiovascular Disease Development by a Direct Action on Endothelial Progenitor Cells
  12. Integrins α4β1 and αVβ3 are Reduced in Endothelial Progenitor Cells from Diabetic Dyslipidemic Mice and May Represent New Targets for Therapy in Aortic Valve Disease
  13. Hypertension Associated With Hyperlipidemia Induced Different MicroRNA Expression Profiles in Plasma, Platelets, and Platelet-Derived Microvesicles; Effects of Endothelial Progenitor Cell Therapy
  14. Diabetes-induced early molecular and functional changes in aortic heart valves in a murine model of atherosclerosis
  15. Platelets of Healthy Origins Promote Functional Improvement of Atherosclerotic Endothelial Progenitor Cells
  16. Sera of Obese Type 2 Diabetic Patients Undergoing Metabolic Surgery Instead of Conventional Treatment Exert Beneficial Effects on Beta Cell Survival and Function: Results of a Randomized Clinical Study
  17. The Distinct Effects of Palmitic and Oleic Acid on Pancreatic Beta Cell Function: The Elucidation of Associated Mechanisms and Effector Molecules
  18. Circulating ectosomes: Determination of angiogenic microRNAs in type 2 diabetes
  19. Understanding the functional role of microRNA-214-3p in atherosclerosis for the identification of novel targeted therapies to prevent or reverse endothelial cell dysfunction and stimulate autophagy
  20. Microparticles of healthy origins improve endothelial progenitor cell dysfunction via microRNA transfer in an atherosclerotic hamster model
  21. Endothelial Progenitor Cell Dysfunction in the Pathogenesis of Vascular Complications of Diabetes
  22. Microparticles: From Biogenesis to Biomarkers and Diagnostic Tools in Cardiovascular Disease
  23. Role of MicroRNA in Endothelial Dysfunction and Hypertension
  24. Effects of transplanted circulating endothelial progenitor cells and platelet microparticles in atherosclerosis development
  25. Vascular complications in diabetes: Microparticles and microparticle associated microRNAs as active players
  26. Midkine proteins in cardio-vascular disease.
  27. Lack of TAFI increases brain damage and microparticle generation after thrombolytic therapy in ischemic stroke
  28. Interaction of platelets with endothelial progenitor cells in the experimental atherosclerosis: Role of transplanted endothelial progenitor cells and platelet microparticles
  29. Activation profile of dorsal root ganglia Iba-1 (+) macrophages varies with the type of lesion in rats
  30. Irbesartan administration therapeutically influences circulating endothelial progenitor cell and microparticle mobilization by involvement of pro-inflammatory cytokines
  31. Circulating Endothelial Progenitor Cell and Platelet Microparticle Impact on Platelet Activation in Hypertension Associated with Hypercholesterolemia
  32. Collagen—Dexamethasone and Collagen-D3Scaffolds for Bone Tissue Engineering
  33. Circulating microparticles and endothelial progenitor cells in atherosclerosis: pharmacological effects of irbesartan
  34. Platelet dysfunction in vascular pathologies and how can it be treated
  35. The promise of EPC-based therapies on vascular dysfunction in diabetes
  36. Enoxaparin reduces adrenergic contraction of resistance arterioles in aging and in aging associated with diabetes via engagement of MAP kinase pathway
  37. Dysfunction of human subcutaneous fat arterioles in obesity alone or obesity associated with Type 2 diabetes
  38. Vascular dysfunction in diabetes: The endothelial progenitor cells as new therapeutic strategy
  39. Integration Properties of Wharton’s Jelly-derived Novel Mesenchymal Stem Cells into Ventricular Slices of Murine Hearts
  40. Platelet activation in hypertension associated with hypercholesterolemia: effects of irbesartan
  41. Intraplatelet Oxidative/Nitrative Stress: Inductors, Consequences, and Control
  42. Increased Vitreous Microparticles in Diabetic Retinopathy
  43. Long-term high glucose concentration influences Akt, ERK1/2, and PTP1B protein expression in human aortic smooth muscle cells
  44. Chronic venous insufficiency is associated with elevated level of circulating microparticles
  45. Nebivolol Induces a Hyperpolarizing Effect on Smooth Muscle Cells in the Mouse Renal Artery by Activation of Beta-2-Adrenoceptors
  46. Protective effects of nebivolol and reversal of endothelial dysfunction in diabetes associated with hypertension
  47. Effect of gap junction uncoupler heptanol on resistance arteries reactivity in experimental models of diabetes, hyperlipemia and hyperlipemia-diabetes
  48. Detection of DNA-bound advanced glycation end-products by immunoaffinity chromatography coupled to HPLC-diode array detection
  49. The cellular mechanisms involved in the vasodilator effect of nebivolol on the renal artery
  50. Superoxide dismutase entrapped-liposomes restore the impaired endothelium-dependent relaxation of resistance arteries in experimental diabetes
  51. The contractile response of the mesenteric resistance arteries to prostaglandin F2α; effects of simultaneous hyperlipemia-diabetes
  52. Enoxaparin—a low molecular weight heparin, restores the altered vascular reactivity of resistance arteries in aged and aged–diabetic hamsters
  53. Beneficial effects of L -arginine supplementation in experimental hyperlipemia-hyperglycemia in the hamster
  54. Mechanisms of decreased bradykinin- induced vasodilation in experimental hyperlipemia-hyperglycemia: contribution of nitric oxide and Ca2+-activated K+ channels
  55. Age-dependent accumulation of advanced glycation endproducts is accelerated in combined hyperlipidemia and hyperglycemia, a process attenuated by L-arginine